Results 181 to 190 of about 80,709 (284)

Darbepoetin and Infantile Hemangioma in Premature Infants. [PDF]

open access: yesJ Clin Med
Shoris I   +7 more
europepmc   +1 more source

Risk of Heart Failure Hospitalization Associated With Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitors Versus Erythropoiesis‐Stimulating Agents: A Nationwide Claims‐Based Cohort Study

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 9, September 2026.
ABSTRACT Purpose Hypoxia‐inducible factor prolyl hydroxylase inhibitors (HIF‐PHIs) are increasingly used to treat renal anemia in patients with chronic kidney disease (CKD). We evaluated the risk of heart failure associated with HIF‐PHIs compared with erythropoiesis‐stimulating agents (ESAs) in routine clinical practice.
Yuki Kunitsu   +4 more
wiley   +1 more source

Anemia of Inflammation in Solid Tumor Patients and Practical Education for Oncologists and Nurses

open access: yesThoracic Cancer, Volume 17, Issue 17, September 2026.
Tumor‐ and immune‐derived cytokines including IL‐6, IL‐1β, TNF‐α, TGF‐β, IL‐10, and IFN‐γ drive anemia of inflammation: IL‐6/TNF‐α upregulate hepatic hepcidin to block iron export, while other cytokines suppress erythropoiesis and shorten red cell survival.
Xiaoyan Si   +5 more
wiley   +1 more source

Computational Screening of Microbial Metabolites as Erythropoietin (EPO) Mimetics for the Treatment of Anemia. [PDF]

open access: yesBiomed Eng Comput Biol
Hasan MN   +8 more
europepmc   +1 more source

Oxygenaging: A Physiological Framework for Geroscience

open access: yesAging Cell, Volume 25, Issue 9, September 2026.
Mechanisms of aging disrupt oxygen homeostasis through three converging processes: oxygen‐cascade impairment, microvascular dysfunction, and molecular maladaptation. “Oxygenaging” integrates these domains to explain how declining oxygen delivery and utilization drive mitochondrial instability and amplify the effect of the hallmarks of aging.
Stefano Donega   +6 more
wiley   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

open access: yesAllergy, Volume 81, Issue 9, Page 3039-3070, September 2026.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
Franziska Roth‐Walter   +20 more
wiley   +1 more source

Renin-angiotensin-aldosterone system inhibition exacerbates anemia in sickle cell disease.

open access: yesBlood
Eskandari N   +11 more
europepmc   +1 more source

Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-Thalassemia. [PDF]

open access: yesAm J Hematol
Sheth S   +25 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy